Skip to main content
Clinical Trials/NCT06034522
NCT06034522
Active, not recruiting
Not Applicable

A Single-Arm, Prospective, Clinical Investigation Evaluating the Safety and Feasibility of Adipearl Implantation in the Face of Adult Subjects

Volumina Medical S.A.1 site in 1 country18 target enrollmentStarted: November 25, 2023Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Volumina Medical S.A.
Enrollment
18
Locations
1
Primary Endpoint
Safety of Investigational Medical Device

Overview

Brief Summary

Adipearl is an injectable filler intended to be injected subcutaneously in the face.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
22 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Subject having given freely and expressly informed consent;
  • Subject deemed by the Investigator to be medically fit for injection of the product;
  • Female or male subjects aged 22 to 65 years (inclusive);

Exclusion Criteria

  • Pregnant or nursing woman or planning a pregnancy during the study.
  • Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
  • Subject participating to another research study.
  • Subject with the presence of any condition, which in the opinion of the Principal Investigator, that makes her/him unable to complete the study per protocol.

Outcomes

Primary Outcomes

Safety of Investigational Medical Device

Time Frame: Up to 6 months

Collection of Injection Site Reactions and Adverse Events during the study.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Volumina Medical S.A.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials